Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
04/23/2014 | CN103735596A Anti-tumor composition |
04/23/2014 | CN103735580A Oenothera biennis oil soft capsule and preparation method thereof |
04/23/2014 | CN103735562A Ganoderma applanatum polysaccharide oral liquid and preparation method thereof |
04/23/2014 | CN103735560A Methods of treating cancer and other conditions or disease states using lfmau and ldt |
04/23/2014 | CN103735557A Application of Ilexsaponin A1 in preparation of anti-tumor medicament |
04/23/2014 | CN103735555A Cucurbitacin medicinal composition and pharmaceutical application thereof |
04/23/2014 | CN103735537A Application of xanthohumol in preparation of drug or health-care product for inhibiting alpha-glucosaccharase activity |
04/23/2014 | CN103735536A Total cucurbitacin phosphatidyl cholate mixed micelle oral quick-absorption membrane and preparation method thereof |
04/23/2014 | CN103735533A Organic and inorganic compound nano-capsule agent and preparation method thereof |
04/23/2014 | CN103735532A Lutein ester microcapsule and preparation method thereof |
04/23/2014 | CN103735523A Peretinoin medicinal composition |
04/23/2014 | CN103735514A Polyethylene glycol vitamin E succinate and calprotectin modified nanoparticle and preparation method thereof |
04/23/2014 | CN103735513A 20(s)-protopanoxadiol nano-particle and preparation method thereof |
04/23/2014 | CN103735511A Preparation method of magnetic drug-carrying liposome |
04/23/2014 | CN103735509A Miboplatin liposome and preparation method thereof |
04/23/2014 | CN103735507A Method for preparation of paclitaxel liposome by ethanol injection |
04/23/2014 | CN103735504A Irinotecan nano lipid binding preparation and preparation method thereof |
04/23/2014 | CN103735497A Liquiritigenin injection and preparation method and application thereof |
04/23/2014 | CN103734920A Green herbal medicine bra |
04/23/2014 | CN103734720A Anti-tumor slow-release flavoring composition |
04/23/2014 | CN103734373A Bamboo-shaving healthcare tea for brain tumor |
04/23/2014 | CN103191425B Combination medicine containing rituximab and lightyellow sophora root |
04/23/2014 | CN103055006B Effective part of Houttuynia cordata as well as extracting method and application thereof |
04/23/2014 | CN103028085B Traditional Chinese medicine preparation for treating cutaneous hemangioma |
04/23/2014 | CN102988691B Preparation method and application of liver-strengthening tablet |
04/23/2014 | CN102961753B Copper sulfide/mesoporous silicon dioxide core-shell nano material as well as preparation method and application thereof |
04/23/2014 | CN102863484B Fructose glycation mangiferin and preparation method and application thereof |
04/23/2014 | CN102834008B Processes of synthesizing dihydropyridophthalazinone derivatives |
04/23/2014 | CN102796235B Copolymer based on environmental response and preparation method thereof |
04/23/2014 | CN102793913B Tumor vaccine of recombinant murine EPS8 gene, and preparation method and application thereof |
04/23/2014 | CN102755292B Vesicle-type medication system containing metformin, and application thereof |
04/23/2014 | CN102727493B Applications of TEMPOL derivatives as anti-tumor drugs |
04/23/2014 | CN102716495B Multifunctional poly(malic acid) carried drug for targeting treatment of tumors |
04/23/2014 | CN102688264B New use of Primula sikkmensis Hook or extract thereof |
04/23/2014 | CN102585033B Hu shaddock pectin with anti-tumor efficacy and preparation method of hu shaddock pectin |
04/23/2014 | CN102558143B Derivant III of natural product Bostrycin and preparation method and purpose thereof |
04/23/2014 | CN102558081B Preparation method of N1, N4-duel substitution phenyl group-3, 6-dimethyl-1,2,4,5-tetrazine-1,4-dimethyl amide |
04/23/2014 | CN102471371B Homing peptide for tumor vasculature |
04/23/2014 | CN102464664B Dilactone derivative, and preparation method and application thereof |
04/23/2014 | CN102382092B Novel isopentene flavone compounds and application thereof |
04/23/2014 | CN102342931B Injectable parenteral medicinal preparation of temozolomide and preparation method thereof |
04/23/2014 | CN102250138B Germatrane compound as well as preparation method and application thereof |
04/23/2014 | CN102229962B Oncolytic adenovirus vector for modifying and expressing two exogenous genes by fibrin, construction method and application of vector |
04/23/2014 | CN102229640B Application of triterpenoid saponins compound extracted from anemone taipaiensis |
04/23/2014 | CN102212108B Determination and application of human RACK1 (receptor for activated C kinase 1) epitope interacting with MKK7 (mitogen-activated protein kinase kinase 7) |
04/23/2014 | CN102171210B Imidazopyridin-2-on derivative |
04/23/2014 | CN102137846B N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275)polymorph B |
04/23/2014 | CN102083814B Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same |
04/23/2014 | CN102068496B Radiosensitizer compositions comprising schisandra chinensis(turcz.)baill |
04/23/2014 | CN101977908B (pyrazolyl carbonyl)imidazolidinone derivatives for the treatment of retroviral diseases |
04/23/2014 | CN101880306B Stauntonia brachyanthera Hand-Mazz saponins components as well as preparation method and application thereof |
04/23/2014 | CN101805349B Furan-azo- [3,2-g] chromene compound and application thereof |
04/23/2014 | CN101781283B Thioredoxin reductase inhibiter compounds and preparation method and application thereof |
04/23/2014 | CN101754956B Substituted indazole derivatives active as kinase inhibitors |
04/23/2014 | CN101325968B Anti-CTLA-4 antibody compositions |
04/23/2014 | CN101229997B 2-methylene-5-substituted methylene cyclopentanone derivatives and uses thereof |
04/22/2014 | US8703942 Small-molecule Hsp90 inhibitors |
04/22/2014 | US8703930 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
04/22/2014 | US8703908 Expression and export of angiogenesis inhibitors as immunofusins |
04/22/2014 | US8703792 C-1 analogs of pancratistatin and 7-deoxypancratistatin and processes for their preparation |
04/22/2014 | US8703777 Certain chemical entities, compositions and methods |
04/22/2014 | US8703755 Analogs of benzoquinone-containing ansamycins and methods of use thereof |
04/22/2014 | US8703752 Use of mifepristone and derivatives therefor as Hedgehog protein signaling pathway modulators and applications of same |
04/22/2014 | US8703746 Compounds as receptor modulators with therapeutic utility |
04/22/2014 | US8703729 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene |
04/22/2014 | US8703725 Nutritional compositions |
04/22/2014 | US8703712 Targeting cancer stem cells with DR5 agonists |
04/22/2014 | US8703709 Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors |
04/22/2014 | US8703211 Agent and method for treating cancer comprising strontium, amino acid(s) and mineral agent(s) |
04/22/2014 | US8703199 Pharmaceutical compositions of adsorbates of amorphous drug |
04/22/2014 | US8703143 Antibodies of the ED-B domain of fibronectin, their construction and uses |
04/22/2014 | US8703133 Antibody variants |
04/22/2014 | CA2710194C Inhibitors of p13 kinase |
04/22/2014 | CA2632618C Demethylpenclomedine analogs and their use as anticancer agents |
04/22/2014 | CA2627623C Methods for inhibiting protein kinases |
04/22/2014 | CA2623360C Squaric acid derivatives as inhibitors of histone deacetylase |
04/22/2014 | CA2597813C Chemical compounds |
04/22/2014 | CA2589992C Treatment of solid cancers |
04/22/2014 | CA2496508C Cancer therapy using beta glucan and antibodies |
04/22/2014 | CA2398998C Cd40-binding apc-activating molecules |
04/22/2014 | CA2345209C Antisense modulation of integrin .alpha.4 expression |
04/17/2014 | WO2014059383A1 Gsk3 inhibitors and methods of use thereof |
04/17/2014 | WO2014059314A1 Treating brain cancer using agelastatin a (aa) and analogues thereof |
04/17/2014 | WO2014059305A1 Compounds for treating rac-gtpase mediated disorder |
04/17/2014 | WO2014059251A1 Enhancement of the immune response |
04/17/2014 | WO2014059244A1 Silk reservoirs for sustained delivery of anti-cancer agents |
04/17/2014 | WO2014059199A1 Hemoglobin-based oxygen carrier-containing pharmaceutical composition for cancer targeting treatment and prevention of cancer recurrence |
04/17/2014 | WO2014059117A1 Cd28 expression during lenalidomide immune modulation |
04/17/2014 | WO2014059034A2 Nad biosynthesis and precursors for the treatment and prevention of cancer and proliferation |
04/17/2014 | WO2014059022A1 Nanoparticles for targeted delivery of multiple therapeutic agents and methods of use |
04/17/2014 | WO2014058947A1 Compositions and methods for treating cancer using pi3k inhibitor and anti-cd19 maytansinoid immunoconjugate |
04/17/2014 | WO2014058920A1 Methods of targeting mir-223 expression to ablate leukemic cells |
04/17/2014 | WO2014058785A1 Combination therapy |
04/17/2014 | WO2014058591A1 Targeted nuclear fusion tumor therapy |
04/17/2014 | WO2014058252A1 Ph-sensitive block copolymer containing cinnamaldehyde derivatives, and method for preparing same |
04/17/2014 | WO2014058079A1 Electrostatic-bonding-type vesicle including metal microparticles |
04/17/2014 | WO2014058078A1 Process for producing dihydro-2h-pyran derivatives |
04/17/2014 | WO2014058035A1 Novel spirooxindole derivative and process for producing the same |
04/17/2014 | WO2014058000A1 Serotonin 2b receptor antagonist |
04/17/2014 | WO2014057957A1 Steroid compound, and medicine comprising same |